This roundtable discussion will focus on understanding widespread challenges and best practices for developing a lab strategy. We'll delve into critical topics like sample tracking across various labs, selecting the right labs for primary and secondary endpoints, and taking a risk-based approach to vendor oversight.
Please note: This session is for BioPharma organizations only.
